AnteoTech Limited (ASX:ADO)
Australia · Delayed Price · Currency is AUD | Market Cap | 68.46M +10.0% |
| Revenue (ttm) | 405.76K +110.4% |
| Net Income | -5.97M |
| EPS | -0.00 |
| Shares Out | 3.26B |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,548,939 |
| Open | 0.0210 |
| Previous Close | 0.0210 |
| Day's Range | 0.0200 - 0.0220 |
| 52-Week Range | 0.0100 - 0.0490 |
| Beta | 1.07 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 27, 2026 |
About AnteoTech
AnteoTech Limited develops, manufactures, commercializes, and distributes products for clean energy technology and life science markets primarily in Australia, Asia, Europe, and North America. The company’s products include AnteoBind, a metal-ion complex-based activation technology that offers an alternative to conventionally used chemistries for the life sciences industry; AnteoBind NXT solution for the development of diagnostic tests; AnteoBind Micro and Micro Kit, a micro-particle-based assay development and bioseparation; AnteoBind Sub-Micr... [Read more]
Financial Performance
In fiscal year 2025, AnteoTech's revenue was 968,878, an increase of 110.44% compared to the previous year's 460,397. Losses were -6.76 million, -23.89% less than in 2024.
Financial StatementsNews
AnteoTech Earnings release: Q4 2026
AnteoTech released its Q4 2026 earnings on July 19, 2026, summarizing the period's financial results.
AnteoTech Slides: Investor presentation
AnteoTech has posted slides in relation to its latest quarterly earnings report, which was published on June 10, 2026.
AnteoTech Slides: Investor presentation
AnteoTech has posted slides in relation to its latest quarterly earnings report, which was published on April 22, 2026.
AnteoTech Slides: Q3 2026
AnteoTech has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on April 19, 2026.
AnteoTech Earnings release: Q3 2026
AnteoTech released its Q3 2026 earnings on April 19, 2026, summarizing the period's financial results.
AnteoTech Transcript: NWR Virtual Healthcare Conference
The business is focused on in vitro diagnostics, targeting new product development with AnteoBind NXT, and expanding into the chemiluminescence market. Strategic partnerships, increased sales efforts, and progress with a major life sciences company are key catalysts for growth in the next year.
AnteoTech Slides: NWR Virtual Healthcare Conference
AnteoTech has posted slides in relation to its latest quarterly earnings report, which was published on March 25, 2026.
AnteoTech Slides: Investor presentation
AnteoTech has posted slides in relation to its latest quarterly earnings report, which was published on March 24, 2026.
AnteoTech Earnings Call Transcript: H1 2026
Streamlined operations and a successful AUD 3.5M capital raise have positioned the company for growth, with a strong sales pipeline in batteries and life sciences, and targeted expansion in the US, South Korea, and India.
AnteoTech Quarterly report: H1 2026
AnteoTech has published its H1 2026 quarterly earnings report on March 1, 2026.
AnteoTech Slides: H1 2026
AnteoTech has posted slides in relation to its H1 2026 quarterly earnings report, which was published on March 1, 2026.
AnteoTech Earnings release: Q2 2026
AnteoTech released its Q2 2026 earnings on January 29, 2026, summarizing the period's financial results.
AnteoTech Slides: Investor Presentation
AnteoTech has posted slides in relation to its latest quarterly earnings report, which was published on December 11, 2025.
AnteoTech Transcript: AGM 2025
The AGM highlighted strong revenue growth, successful product launches, and strategic expansion into new markets. All resolutions passed except the spill motion, with shareholders expressing confidence in the board and management's direction.
AnteoTech Slides: FY 2025
AnteoTech has posted slides in relation to its FY 2025 quarterly earnings report, which was published on November 25, 2025.
AnteoTech Earnings release: Q1 2026
AnteoTech released its Q1 2026 earnings on October 26, 2025, summarizing the period's financial results.
AnteoTech Earnings Call Transcript: H2 2025
Cost reductions and doubled revenue marked the year, with accelerated R&D rebates and strong commercial focus. High-silicon battery milestones and expanded global partnerships drive growth, while complex supply chains and long sales cycles remain key challenges.
AnteoTech Annual report: H2 2025
AnteoTech has published its H2 2025 annual report on August 28, 2025.
AnteoTech Slides: H2 2025
AnteoTech has posted slides in relation to its H2 2025 quarterly earnings report, which was published on August 28, 2025.